As SOX2 represents one of the key factors involved in melanoma stemness and tumorigenicity (11), we evaluated whether the role of SOX2 phosphorylation in limiting BRAFi sensitivity could be related to the induction of stem-like features, which are typically associated with drug resistance (25). This evidence concerns the gene SOX2 and melanoma.